DR. HABIB SKAFF

Corporate Board Profile

Tech Score: 100/100

← Back to All Directors

Software Technology Evidence

5 mention(s) identify DR. HABIB SKAFF as having software/technology expertise.

Company Filing Date Evidence Reason
VOLITIONRX LTD 2015-09-16 Dr. Habib Skaff is a synthetic chemist specializing in the area of nanotechnology. Dr. Skaff is a synthetic chemist specializing in nanotechnology and has co-authored numerous scientific papers and patents, indicating a strong technical background.
VOLITIONRX LTD 2016-08-22 Dr. Skaff works as a synthetic chemist specializing in the area of nanotechnology. Dr. Skaff has a background in synthetic chemistry and nanotechnology, and has co-authored numerous scientific papers and holds patents, indicating a strong technical background.
VOLITIONRX LTD 2017-07-24 Dr. Skaff works as a synthetic chemist specializing in the area of nanotechnology. Dr. Skaff has a background in synthetic chemistry and nanotechnology, and has co-authored numerous scientific papers, indicating a strong technical background that may include programming skills.
VOLITIONRX LTD 2018-07-20 Dr. Skaff co-founded Intezyne Technologies in 2004 and served as its Chief Executive Officer until 2016. Dr. Skaff has co-authored scientific papers and is a co-inventor on patents in biotechnology, indicating a strong technical background in related fields.
VOLITIONRX LTD 2019-04-29 Dr. Skaff co-founded Intezyne Technologies in 2004 and served as its Chief Executive Officer until 2016. ... Dr. Skaff works as a synthetic chemist specializing in the area of nanotechnology. Dr. Skaff has a background in synthetic chemistry and nanotechnology, and has co-authored numerous scientific papers and holds patents, indicating a strong technical background.

VOLITIONRX LTD

Filing Date Source Excerpt
2015-09-16 Dr. Habib Skaff is a synthetic chemist specializing in the area of nanotechnology.
2016-08-22 Dr. Skaff works as a synthetic chemist specializing in the area of nanotechnology.
2017-07-24 Dr. Skaff works as a synthetic chemist specializing in the area of nanotechnology.
2018-07-20 Dr. Skaff co-founded Intezyne Technologies in 2004 and served as its Chief Executive Officer until 2016.
2019-04-29 Dr. Skaff co-founded Intezyne Technologies in 2004 and served as its Chief Executive Officer until 2016. ... Dr. Skaff works as a synthetic chemist specializing in the area of nanotechnology.

Data sourced from SEC filings. Last updated: 2025-07-01